A detailed history of Carnegie Capital Asset Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 104,819 shares of AMGN stock, worth $28.7 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
104,819
Previous 99,420 5.43%
Holding current value
$28.7 Million
Previous $32 Million 14.72%
% of portfolio
0.81%
Previous 0.96%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 14, 2025

BUY
$258.78 - $328.31 $1.4 Million - $1.77 Million
5,399 Added 5.43%
104,819 $27.3 Million
Q3 2024

Oct 10, 2024

BUY
$309.38 - $337.38 $1.13 Million - $1.23 Million
3,660 Added 3.82%
99,420 $32 Million
Q2 2024

Jul 19, 2024

BUY
$262.75 - $319.31 $533,119 - $647,879
2,029 Added 2.16%
95,760 $29.9 Million
Q1 2024

May 03, 2024

BUY
$268.87 - $324.56 $1.8 Million - $2.17 Million
6,678 Added 7.67%
93,731 $26.6 Million
Q4 2023

Jan 29, 2024

BUY
$255.7 - $288.46 $995,440 - $1.12 Million
3,893 Added 4.68%
87,053 $25.1 Million
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $705,146 - $875,458
3,225 Added 4.03%
83,160 $22.4 Million
Q2 2023

Aug 04, 2023

BUY
$214.27 - $253.37 $350,759 - $414,766
1,637 Added 2.09%
79,935 $17.7 Million
Q1 2023

Apr 19, 2023

BUY
$225.79 - $275.2 $739,010 - $900,729
3,273 Added 4.36%
78,298 $18.9 Million
Q4 2022

Jan 23, 2023

BUY
$229.03 - $291.01 $732,208 - $930,358
3,197 Added 4.45%
75,025 $0
Q3 2022

Oct 13, 2022

BUY
$224.46 - $253.15 $680,562 - $767,550
3,032 Added 4.41%
71,828 $16.2 Million
Q2 2022

Aug 02, 2022

SELL
$230.71 - $256.74 $2.52 Million - $2.8 Million
-10,903 Reduced 13.68%
68,796 $16.7 Million
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $2.44 Million - $2.72 Million
10,579 Added 15.31%
79,699 $19.4 Million
Q1 2022

Apr 11, 2022

BUY
$219.27 - $242.57 $372,759 - $412,369
1,700 Added 2.52%
69,120 $16.7 Million
Q4 2021

Jan 21, 2022

SELL
$198.88 - $227.6 $2.71 Million - $3.1 Million
-13,629 Reduced 16.82%
67,420 $15.2 Million
Q3 2021

Oct 08, 2021

BUY
$212.27 - $248.7 $286,564 - $335,745
1,350 Added 1.69%
81,049 $17.2 Million
Q2 2021

Jul 16, 2021

BUY
$233.58 - $259.14 $279,828 - $310,449
1,198 Added 1.53%
79,699 $19.4 Million
Q1 2021

Apr 12, 2021

BUY
$221.91 - $258.6 $654,412 - $762,611
2,949 Added 3.9%
78,501 $19.6 Million
Q4 2020

Feb 08, 2021

BUY
$216.38 - $257.67 $428,432 - $510,186
1,980 Added 2.69%
75,552 $17.4 Million
Q3 2020

Oct 13, 2020

BUY
$234.65 - $260.95 $679,546 - $755,711
2,896 Added 4.1%
73,572 $18.7 Million
Q2 2020

Jul 09, 2020

SELL
$197.81 - $242.74 $5,934 - $7,282
-30 Reduced 0.04%
70,676 $16.6 Million
Q1 2020

May 08, 2020

SELL
$182.24 - $241.7 $501,160 - $664,675
-2,750 Reduced 3.74%
70,706 $14.4 Million
Q4 2019

Feb 13, 2020

BUY
$189.21 - $243.2 $1.91 Million - $2.45 Million
10,086 Added 15.92%
73,456 $17.7 Million
Q3 2019

Nov 20, 2019

SELL
$174.11 - $208.62 $964,569 - $1.16 Million
-5,540 Reduced 8.04%
63,370 $12.3 Million
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $361,572 - $423,844
-2,169 Reduced 3.05%
68,910 $12.7 Million
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $3.42 Million - $3.86 Million
18,926 Added 36.29%
71,079 $13.5 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $2.27 Million - $2.65 Million
12,722 Added 32.26%
52,153 $10.2 Million
Q3 2018

Nov 27, 2018

SELL
$185.29 - $208.89 $2.87 Million - $3.23 Million
-15,463 Reduced 28.17%
39,431 $7.69 Million
Q2 2018

Aug 16, 2018

BUY
$166.05 - $186.51 $1.81 Million - $2.04 Million
10,919 Added 24.83%
54,894 $10.6 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $2.21 Million - $2.58 Million
13,033 Added 42.12%
43,975 $7.64 Million
Q4 2017

Feb 12, 2018

BUY
$168.79 - $188.59 $496,411 - $554,643
2,941 Added 10.5%
30,942 $5.49 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $595,385 - $679,769
3,559 Added 14.56%
28,001 $5.06 Million
Q2 2017

Aug 14, 2017

BUY
N/A
24,442
24,442 $4.26 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Carnegie Capital Asset Management, LLC Portfolio

Follow Carnegie Capital Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carnegie Capital Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Carnegie Capital Asset Management, LLC with notifications on news.